Bradley Richards
Physician Assistant · West Jordan, UTNPI 1790931210
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 356 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 51 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 356 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$619
- Lundbeck LLC$591
- Tersera Therapeutics LLC$498
- GSK$478
- AstraZeneca$444
- plus $3K from 45 others
What the payments were for
- Consulting fees$4236%
- Food & beverage$6,25894%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QUZYTTIR$423
How this compares
$6,681 in reported general payments places this provider in the 95th percentile of 1,543 physician assistant providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 11 | $12,737 |
| Tizanidine Hcl | 23 | $444 |
| Methylphenidate Hcl | 11 | $330 |
| Duloxetine Hcl | 11 | $271 |
| Alprazolam | 11 | $197 |
| Mirtazapine | 12 | $194 |
| Lisinopril | 12 | $138 |
| Zolpidem Tartrate | 11 | $130 |
| Omeprazole | 11 | $118 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $229 | $12,73711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,543 physician assistant providers in Utah.
Other physician assistant in West Jordan
- Luke JenkinsWest Jordan$46K
- Kevin PetersonWest Jordan$13K
- Todd SchauersWest Jordan$10K
- Regan BrooksSlc$606K
- Keri HolyoakMidvale$438K
- Jill EricksonSalt Lake City$179K
- Vanessa Beard-ElyMurray$80K
- Natalie BeeSalt Lake City$63K
- Jasmin CharlesTaylorsville$46K
- Chanise FrandsenSandy$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.